The crosstalk between directly acting antivirals and chronic HCV patients with different stages of renal affection: A multicenter study

Theodor Bilharz Research Institute

Bibliographic Information

Authors: El-Kassas M.; El Balakosy A.; Elbadry M.; Ahmed O.A.; Anwar C.A.; Algaber M.A.; Michael T.G.; El Tahan A.; Alborai M.; Meleak G.; Tahoon M.; Sherief A.; Raafat K.; Radwan H.; Eysa B.; Abdelaziz H.E.; Ahmed Y.; Aboul-Ezz M.; Awad A.

Journal: Clinics and Research in Hepatology and Gastroenterology

Publisher: Elsevier Masson s.r.l.

Publication Date: December 2023

Volume / Issue: Volume 47 / Issue 10

Article No.: 102232

ISSN: 22107401

DOI: 10.1016/j.clinre.2023.102232

Scopus: View on Scopus

PubMed: 37866814

Document Type: Letter


Authors and Affiliations

El-Kassas M., Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt; El Balakosy A., Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Elbadry M., Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt; Ahmed O.A., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Anwar C.A., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Algaber M.A., Gastroenterology & Hepatology, Police Authority Hospitals, Giza, Egypt; Michael T.G., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; El Tahan A., New Cairo Viral Hepatitis Treatment Unit, New Cairo Hospital, Cairo, Egypt; Alborai M., Department of Internal Medicine, Al-Azhar University, Cairo, Egypt; Meleak G., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Tahoon M., Department Epidemiology and Preventive Medicine, National Liver Institute, Menoufia University, El Kom, Shebin, Egypt; Sherief A., Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Raafat K., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Radwan H., Internal Medicine Department, Medicine and Clinical Studies Research Institute, National Research Centre, Cairo, Egypt; Eysa B., Hepatology and Gastroenterology Department, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; Abdelaziz H.E., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Ahmed Y., Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Aboul-Ezz M., Hepatology and Gastroenterology Department, Theodor Bilharz Research Institute, Cairo, Egypt; Awad A., Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt


Abstract

[No abstract available]


Keywords

Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Kidney; antivirus agent; daclatasvir; ombitasvir; paritaprevir; ribavirin; simeprevir; sofosbuvir; chronic hepatitis C; chronic kidney failure; dialysis; disease classification; disease severity; drug efficacy; drug safety; estimated glomerular filtration rate; Food and Drug Administration; high risk population; human; kidney failure; kidney function; Letter; liver cirrhosis; molecular interaction; sustained virologic response; treatment response; clinical trial; complication; genetics; multicenter study


Citation Information

Scopus Citations: 0


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer